Concepedia

Author

Hideki Nakakuma

Kumamoto University

Also Known As

H NAKAKUMA, H Nakakuma, H. Nakakuma, Hideki NAKAKUMA, Hideki Nakakuma, Hideki Nakakuma *, Nakakuma, H., 中熊 秀喜

125

Publications

2.1K

Citations

26

H-Index

69

Concepts

All Affiliations

Kumamoto UniversityWakayama Medical UniversityThe University of OsakaJichi Medical UniversityThe University of Tokyo
HN

About

Hideki Nakakuma is an author at Kumamoto University specializing in medicine, hematology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

24

1.1K

2

Health Sciences

4

4

74

3

Natural Sciences

2

2

120

4

Public Health

2

2

271

5

Allergy

2

2

40

Hideki Nakakuma

×

44

Publications

1.8K

Citations

25

H-Index

YearCitations

Clinical Course and Flow Cytometric Analysis of Paroxysmal Nocturnal Hemoglobinuria in the United States and Japan

Jun‐ichi Nishimura, Yuzuru Kanakura, Russell E. Ware,

Medicine

2004

259

The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML

Kensuke Kojima, Masaya Shimanuki, Masato Shikami,

Leukemia

2008

115

PIG-W Is Critical for Inositol Acylation but Not for Flipping of Glycosylphosphatidylinositol-Anchor

Yoshiko Murakami, Uamporn Siripanyapinyo, Yeongjin Hong,

Molecular Biology of the Cell

2003

109

Apoptosis Resistance of Blood Cells From Patients With Paroxysmal Nocturnal Hemoglobinuria, Aplastic Anemia, and Myelodysplastic Syndrome

Kentaro Horikawa, Hideki Nakakuma, Tatsuya Kawaguchi,

Blood

1997

99

Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes

Masako Iwanaga, Koichi Furukawa, Tatsuhiko Amenomori,

British Journal of Haematology

1998

86

Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP

Nobuyoshi Hanaoka, Tatsuya Kawaguchi, Kentaro Horikawa,

Blood

2005

82

Eμ/miR-125b transgenic mice develop lethal B-cell malignancies

Yutaka Enomoto, Jiro Kitaura, Kinta Hatakeyama,

Leukemia

2011

81

Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial

Yuzuru Kanakura, Kazuma Ohyashiki, Tsutomu Shichishima,

International Journal of Hematology

2011

71

Concomitant inhibition of Mdm2-p53 interaction and Aurora kinases activates the p53-dependent postmitotic checkpoints and synergistically induces p53-mediated mitochondrial apoptosis along with reduced endoreduplication in acute myelogenous leukemia

Kensuke Kojima, Marina Konopleva, Twee Tsao,

Blood

2008

68

Decreased susceptibility of leukemic cells with PIG-Amutation to natural killer cells in vitro

Shoichi Nagakura, Sonoko Ishihara, Daniel E. Dunn,

Blood

2002

59

Page 1